Brain Energy & Nootropic Neuroscience · · 21 min read · By

Dihexa vs Creatine for Brain Fog & Cognitive Energy: The 2026 UK Review

Dihexa vs creatine for brain fog and cognitive energy - 2026 UK evidence review illustration

Creatine has quietly become the supplement of the moment — and it is being sold for your brain, not just your biceps. UK and US creatine sales surged around 72% in the year to late 2025, driven by women, menopausal users and anyone chasing more mental energy; searches for creatine gummies are up more than 1,300%. At the same time, people fighting brain fog keep finding Dihexa — a synaptogenic peptide that modulates the HGF/c-Met pathway — and asking which one they should try. This 2026 UK review puts the two side by side. The short version: creatine is a cheap, safe, genuinely evidence-backed way to support cognitive energy, while Dihexa is an unlicensed research chemical with no completed human trials for brain fog and a safety flag creatine simply does not carry. They are not equivalents — and only one of them belongs anywhere near a first attempt at clearer thinking.

Not medical advice. Dihexa (PNB-0408) is an unscheduled research chemical, not an approved treatment for brain fog or any other condition. Creatine is a food supplement, not a medicine, and this page is general information, not a recommendation to take any product — and this site does not sell creatine. Nothing here is medical advice. If you have persistent brain fog, the right first step is a proper assessment with your GP to rule out treatable causes. Read the full legal disclaimer.

Key Findings: Dihexa vs Creatine for Brain Fog & Cognitive Energy

  • Two different tools: Creatine tops up the brain’s phosphocreatine energy buffer; Dihexa is proposed to build synapses via HGF/c-Met. Energy supply versus wiring — not the same job.
  • Creatine has real human evidence: A 2024 Scientific Reports study showed a single dose improved processing speed and working memory during sleep deprivation; meta-analyses report modest memory gains.
  • A 2025 clinical pilot: A University of Kansas Alzheimer’s pilot raised brain creatine ~11% and hinted at cognitive gains — small and uncontrolled, but real clinical work.
  • Dihexa has none of that: There is no completed human trial of Dihexa for brain fog, cognitive energy or any related complaint. The pre-clinical Benoist 2014 data is in animals and cells.
  • Who benefits most from creatine: Older adults, the sleep-deprived, the stressed and vegetarians — groups with lower baseline brain creatine — per the 2023 memory meta-analysis.
  • Safety is not close: Creatine has a strong ISSN safety record; Dihexa amplifies the pro-proliferative c-Met pathway — a specific cancer-relevant concern.
  • The clinical read-across: Dihexa’s closest drug relative, fosgonimeton, missed its Alzheimer’s Phase 3 in 2024 — a caution for the whole mechanism.
  • Bottom line: Neither fixes the cause of brain fog. But if you want a low-risk, evidence-based lever for cognitive energy, creatine is the sensible option and Dihexa is not. Fix sleep, exercise and diet first; treat any medical cause; and leave the unlicensed peptide out of it.

Creatine in 2026: From Gym Bro Powder to “Brain Supplement”

For thirty years creatine was filed under “bodybuilding.” In 2026 it is being marketed as a nootropic. The shift has been dramatic: creatine surged roughly 72% in mainstream retail sales in the year to late November 2025, with the fastest growth coming not from young male athletes but from women, menopausal users and older adults drawn by claims about mood, memory and “mental energy.” Searches for creatine gummies have jumped more than 1,300%, and the powder now turns up in functional drinks and snacks. It has become, in short, the wellness world’s current obsession — which is exactly why anyone with brain fog now bumps into it.

That same brain-fog audience keeps finding this site, because Dihexa is marketed in overlapping communities as a “synaptogenic” cognitive booster. So the question lands naturally: if you want a sharper, less foggy mind, should you reach for the cheap tub of creatine at the pharmacy, or the vial of research-grade peptide? It is a fair question, and unusually for this series the honest answer is not simply “neither.” One of these two has a genuine, if modest, evidence base and an excellent safety record. The other does not. This review explains why, and where each actually sits.

What Creatine Actually Is — and Why the Brain Cares

Creatine is not a stimulant, a hormone or a drug. It is a small nitrogen compound your body already makes (mostly in the liver and kidneys) and that you eat in meat and fish. About 95% is stored in muscle, but the brain holds a meaningful pool too — and the brain is where the cognitive story lives.

The mechanism is all about energy. Every thought, every memory trace, every second of focus is paid for in adenosine triphosphate (ATP), the cell’s energy currency. Neurons burn ATP fast and cannot store much of it. This is where creatine earns its keep: stored as phosphocreatine, it acts as an instant backup battery, donating a phosphate group to regenerate ATP the moment demand outstrips supply. When the brain is stressed — intense mental effort, sleep deprivation, low oxygen, low glucose, or the metabolic strain seen in conditions like ME/CFS — phosphocreatine buys the neuron time.

Supplementing creatine raises brain phosphocreatine by roughly 5–15% in magnetic resonance spectroscopy studies. That is the crucial point for the Dihexa comparison: creatine works by improving the energy supply to existing circuits. It is a metabolic support, not a rebuild. Hold that thought — because Dihexa claims to do something entirely different.

The Human Evidence for Creatine and Cognition

Here is where creatine separates itself from almost every other “brain” supplement, and certainly from Dihexa: there are real randomised human trials, and several of them point the same way.

The sleep-deprivation study: creatine under pressure

The most striking recent result came in 2024, when Gordji-Nejad and colleagues published in Scientific Reports a double-blind study in which a single high dose of creatine (0.35 g/kg) was given to participants kept awake for 21 hours. Compared with placebo, creatine improved processing speed and working memory during sleep deprivation and produced measurable changes in the brain’s high-energy phosphates on imaging. In other words, when the brain’s energy system was pushed toward failure, topping up the phosphocreatine battery helped it hold performance. This is a clean demonstration of the energy-buffer mechanism in living humans — and it maps neatly onto real-world burnout and sleep-loss brain fog.

The meta-analyses: modest but real

Zoom out to the pooled data and the signal is smaller but consistent. A 2023 systematic review and meta-analysis of memory concluded that creatine supplementation improves memory in healthy people, with the clearest benefit in older adults. A broader 2024 meta-analysis of cognition found small improvements in memory, attention and processing speed, and a 2025 systematic review focused on ageing reached broadly the same conclusion for older brains. The recurring theme is telling: creatine helps most when baseline brain stores are low or the system is under strain — older adults, the sleep-deprived, the stressed, and vegetarians and vegans who get little dietary creatine.

The 2025 Alzheimer’s pilot: the newest data point

The freshest development is clinical. In 2025, a University of Kansas pilot trial in Alzheimer’s & Dementia: Translational Research & Clinical Interventions gave 20 g/day of creatine monohydrate to people with Alzheimer’s disease for eight weeks. It was primarily a feasibility study, and it was small and uncontrolled — so it does not show creatine treats Alzheimer’s. But brain total creatine rose by about 11% on imaging, and there were encouraging signals on several cognitive tests, enough to justify larger controlled trials. Modest as it is, this is exactly the kind of transparent, hypothesis-testing clinical work that the Dihexa field has never produced.

The simplified picture. Creatine is not a miracle and its cognitive effects are modest. But they are real, replicated and strongest exactly where brain fog bites — ageing, sleep loss and metabolic stress. That is a genuinely different evidential world from “promising in mice.”

Where Dihexa Enters: A Different Mechanism, a Thinner Evidence Base

Now the other side of the comparison. Dihexa (PNB-0408) is a small peptide derived from angiotensin IV, developed as a positive modulator of the HGF/c-Met pathway. Hepatocyte growth factor (HGF), acting on its receptor c-Met, drives synaptogenesis — the formation of new synaptic connections — through the PI-3K/AKT and MAPK cascades, and MET signalling stays active in the adult hippocampus and prefrontal cortex. In the original Benoist 2014 JPET work, Dihexa improved learning in rodent models and its effects depended on the HGF/Met system.

Compare the two mechanisms directly and the contrast is clean:

  • Creatine = energy. It refuels existing circuits so they can keep firing under load. Fast-acting, metabolic, reversible.
  • Dihexa = wiring. It is proposed to build new synapses via growth-factor signalling — a slower, structural, plasticity-based idea, conceptually adjacent to BDNF.

On paper, “builds new synapses” sounds more powerful than “tops up the battery.” But there is a decisive asymmetry: creatine’s modest claim is backed by human trials, while Dihexa’s grander claim rests almost entirely on animal and cell data. There is no completed, published human efficacy trial of Dihexa for brain fog, cognitive energy, memory or focus. A mechanism that is impressive in a slide deck is not the same as a benefit demonstrated in people — a distinction the research and studies page returns to repeatedly.

Head to Head: Creatine vs Dihexa on the Things That Matter

Stripped of hype, a fair comparison comes down to a handful of practical axes.

Evidence

Creatine: hundreds of human trials overall, a dedicated and growing cognition literature, multiple meta-analyses and a 2025 clinical pilot. Dihexa: pre-clinical only; no completed human trial in any cognitive indication. This is not a close call.

Safety

Creatine: the International Society of Sports Nutrition position stand concludes creatine monohydrate is safe at commonly used doses in healthy people, with no convincing evidence of kidney harm in those with healthy kidneys. Dihexa: unknown long-term safety, no pharmaceutical-grade quality control on “research chemical” material, and a mechanism that amplifies the pro-proliferative c-Met pathway — an oncologically relevant concern across many tumour types. Again, not close.

Legality & access

Creatine: an ordinary, legal food supplement sold in every UK pharmacy and supermarket. Dihexa: not a controlled drug, but not a licensed medicine either; it cannot lawfully be marketed or sold to treat brain fog or enhance cognition under MHRA rules, and personal-use possession sits in a grey zone set out on the UK legal status page.

Cost

Creatine: pennies a day. Dihexa: expensive research-grade peptide of uncertain purity. For a cognitive-energy goal, the risk-adjusted value is lopsided.

The honest scorecard. On evidence, safety, legality and cost, creatine leads on every axis. The only column where Dihexa “wins” is the theoretical ceiling of its mechanism — and a theoretical ceiling with no human data underneath it is not a benefit you can bank.

The Fosgonimeton Parallel: Why the Dihexa Mechanism Deserves Caution

The Dihexa mechanism is not just untested in humans — the one time a closely related mechanism was tested properly, it fell short. Fosgonimeton (ATH-1017), developed by Athira Pharma, is a small-molecule positive modulator of the HGF/MET system — conceptually the same lever Dihexa pulls. It was taken all the way into a Phase 3 Alzheimer’s trial, LIFT-AD, and in 2024 it missed its primary endpoint.

A purpose-built, professionally manufactured HGF/MET modulator, tested in a rigorous trial, failed to show the hoped-for cognitive benefit. That does not prove the pathway is worthless — trials fail for many reasons — but it is a serious caution for anyone assuming an unregulated peptide bought online will outperform a Phase 3 drug. Contrast that with creatine, whose humble energy-buffering claim keeps passing its human tests. When you weigh a mechanism with a high-profile clinical failure against one with quiet, repeated clinical wins, the risk calculus is clear.

What Actually Works for Brain Fog & Cognitive Energy

Neither creatine nor Dihexa fixes the cause of brain fog, and that caveat matters more than either supplement. If your thinking is foggy, the highest-yield moves are unglamorous and well-proven:

  • Rule out a medical cause. Persistent fog can flag B12, iron or vitamin D deficiency, thyroid disease, depression, sleep apnoea, menopause and more. A GP work-up beats any supplement.
  • Fix sleep first. Nothing clears cognitive energy like consolidated sleep — see insomnia & sleep deprivation. Creatine can blunt the damage of a bad night, but it is no substitute for the night.
  • Exercise. Aerobic activity is the most reliable natural driver of BDNF and synaptic plasticity — the very currency Dihexa is hoped to provide.
  • Consider creatine as a low-risk add-on. If you are older, sleep-deprived, highly stressed, or vegetarian, the evidence for a small cognitive-energy benefit is reasonable, the safety record is strong and the cost is trivial.
  • Skip the unproven peptide. Layering an unlicensed research chemical onto an unclear problem adds risk without evidence — the recurring theme of the Dihexa vs nootropics comparison and the stacking guide.

Creatine: Practical, Honest Notes

If you and your doctor decide creatine is worth trying for cognitive energy, a few evidence-based points help set expectations. The standard dose is 3–5 g/day of plain creatine monohydrate; some brain-focused researchers argue higher doses may be needed to shift brain (as opposed to muscle) levels, which is why studies like the sleep-deprivation trial used much larger single doses. Benefits, where they occur, are modest and build over weeks, not minutes. Choose a product with a reputable quality certification, since the supplement market is uneven. People with kidney disease, and anyone pregnant or breastfeeding, should check with a clinician first. And keep the frame realistic: creatine is a gentle support for brain energy, not a treatment for any disease — this site does not sell it and has no stake in whether you take it.

Who Should Not Reach for Dihexa Here

For the specific goal of clearing brain fog or boosting cognitive energy, the honest position is that Dihexa is the wrong tool — a cheaper, safer, better-studied option exists. Beyond that general point, Dihexa should be avoided altogether by:

  • Anyone with a personal or family history of cancer or any proliferative condition, given the pro-proliferative c-Met mechanism.
  • Anyone who is immunosuppressed, in whom a pro-growth signal carries added risk.
  • Anyone pregnant, breastfeeding or planning pregnancy.
  • Anyone taking multiple medications without clinician oversight of an unlicensed addition.
  • Anyone who has not first had a proper work-up for the treatable causes of brain fog listed above.

The Bottom Line

“Creatine for the brain” is one of 2026’s biggest wellness stories, and for once the hype has some substance behind it: a genuine, if modest, human evidence base, a clear energy-buffering mechanism, a 2025 clinical pilot, an excellent safety record and a trivial cost. Dihexa sits on the opposite end of the spectrum — an intriguing synaptogenic mechanism with no completed human trials for cognition, an unknown safety profile, a pro-proliferative c-Met flag, and a closest clinical relative that failed its Alzheimer’s Phase 3. If your aim is a clearer, more energetic mind, the order is simple: fix sleep, move your body, treat any medical cause, and if you want a low-risk lever, creatine is the evidence-based one. A peptide that builds synapses in mice is not the shortcut it appears to be — and it is certainly not a first step. As always on this site: the unglamorous, well-studied path wins, and the unlicensed peptide comes last.

Frequently Asked Questions

Does creatine help with brain fog?

It can modestly. A 2024 Scientific Reports study found a single dose improved processing speed and working memory during sleep deprivation, and meta-analyses report small memory and processing-speed gains, strongest in older, stressed or vegetarian people. It won’t fix an underlying cause, but it has far more evidence than Dihexa does.

Is creatine or Dihexa better for cognitive energy?

Creatine, comfortably, as a first option. It has human trials, a clear phosphocreatine mechanism, a strong safety record and a tiny cost. Dihexa is an unlicensed research chemical with no completed human cognition trials and a c-Met safety concern. They also do different jobs — energy supply versus synapse building.

How does creatine work in the brain?

The brain runs on ATP, and creatine — stored as phosphocreatine — acts as a rapid backup battery, regenerating ATP when neurons burn through it during mental effort, sleep loss or metabolic stress. Supplementing raises brain phosphocreatine roughly 5–15%. This is energy buffering, quite different from Dihexa’s proposed HGF/c-Met synapse building.

What did the 2025 Alzheimer’s creatine study show?

A small University of Kansas pilot gave 20 g/day of creatine for eight weeks to people with Alzheimer’s. Brain creatine rose ~11% and some cognitive measures improved. It was an uncontrolled feasibility study — encouraging enough to justify larger trials, but not proof of treatment. Still, it is more rigorous than anything that exists for Dihexa.

Is creatine safe, and how much should I take?

Creatine monohydrate is among the most studied supplements available; the ISSN position stand considers it safe at usual doses in healthy people, with no convincing kidney harm in healthy kidneys. The typical dose is 3–5 g/day. People with kidney disease, or who are pregnant or breastfeeding, should check with a doctor. This is general information, not medical advice — and this site does not sell creatine.

Can I stack creatine and Dihexa together?

This site does not recommend Dihexa for brain fog, so it does not recommend stacking it with anything. Creatine alone is a reasonable, evidence-based support; adding an unlicensed peptide with a c-Met concern introduces risk without evidence. See the stacking guide for the wider caution.

External Authoritative Sources Cited

Editorial statement: This article is part of a rolling 2026 clinical-context review series examining where Dihexa sits in the evidence hierarchy for specific concerns. We are not clinicians, and we do not sell creatine or any supplement. This page is for education and is not medical advice. See the About page for our editorial approach and the disclaimer for legal scope. If brain fog is affecting your daily life, please speak to your GP.